This company listing is no longer active
Healthcare Services Acquisition Past Earnings Performance
Past criteria checks 2/6
Key information
140.6%
Earnings growth rate
n/a
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Healthcare Services Acquisition makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 0 | 15 | 2 | 0 |
| 30 Jun 22 | 0 | 17 | 3 | 0 |
| 31 Mar 22 | 0 | 3 | 4 | 0 |
| 31 Dec 21 | 0 | 11 | 4 | 0 |
Quality Earnings: HCAR has high quality earnings.
Growing Profit Margin: Insufficient data to determine if HCAR's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Unable to establish if HCAR's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.
Accelerating Growth: Unable to compare HCAR's past year earnings growth to its 5-year average as it has been trading publicly for less than 3 years.
Earnings vs Industry: HCAR earnings growth over the past year (140.6%) exceeded the Capital Markets industry 15.5%.
Return on Equity
High ROE: HCAR's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.